Cushing Capital Partners’s Colgate-Palmolive CL Stock Holding History

Cushing Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$322K	Buy	3,778 +296	+9%	+$26.8K	0.2%	95
2026 Q2	$319K	Sell	3,482 -33	-0.9%	-$2.89K	0.22%	84
2026 Q1	$300K	Sell	3,515 -2,621	-43%	-$234K	0.23%	86
2025 Q4	$485K	Sell	6,136 -3,137	-34%	-$246K	0.36%	65
2025 Q3	$741K	Sell	9,273 -537	-5%	-$45.8K	0.58%	56
2025 Q2	$892K	Sell	9,810 -490	-5%	-$44.7K	0.75%	46
2025 Q1	$965K	Buy	+10,300	New	+$922K	0.87%	45

Other funds holding CL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Cushing Capital Partners's CL Position: Q3 2026 in Review

Cushing Capital Partners increased its Colgate-Palmolive (CL) stake by 8.5% in Q3 2026, buying an estimated $26.8K and bringing the position to 3,778 shares worth $322K. The position accounts for 0.2% of the portfolio, ranked #95.

Cushing Capital Partners first reported a position in CL in Q1 2025 and has held it in 7 quarters since. The position peaked at $965K in Q1 2025. 1,322 funds tracked by Wall St. Rank hold CL as of Q3 2026.

Cushing Capital Partners held 3,778 shares of Colgate-Palmolive worth $322K as of Q3 2026.
Cushing Capital Partners bought 296 Colgate-Palmolive shares in Q3 2026, an estimated $26.8K.
Colgate-Palmolive made up 0.2% of Cushing Capital Partners's portfolio in Q3 2026, its #95 holding.
Cushing Capital Partners first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 7 quarters since.
Cushing Capital Partners's Colgate-Palmolive position peaked at $965K in Q1 2025.
1,322 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Cushing Capital Partners's 13F filing for Q3 2026, filed 20 Oct 2026.